PRAX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.70%

Insider Buying (Last 12 Months): $35,946.90

Insider Selling (Last 12 Months): $0.00

Praxis Precision Medicines Insider Trading History Chart

Praxis Precision Medicines Share Price & Price History

^$46.89

▲ +0.3 (0.64%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

Praxis Precision Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/5/2023	Jill Desimone	Director	Buy	966	$26.25	$25,357.50	966
6/27/2023	Marcio Souza	CEO	Buy	666	$15.90	$10,589.40	3,000
3/24/2023	Dean J Mitchell	Director	Buy	3,333	$12.60	$41,995.80	5,000
3/23/2023	Marcio Souza	CEO	Buy	2,333	$12.90	$30,095.70	15,086
6/16/2022	Lauren Mastrocola	Insider	Buy	200	$28.95	$5,790.00	2,092
6/13/2022	Alex Nemiroff	General Counsel	Buy	500	$24.45	$12,225.00	2,623
6/9/2022	Timothy Edwin Kelly	CFO	Buy	666	$26.40	$17,582.40	2,699
6/8/2022	Dean J Mitchell	Director	Buy	1,666	$27.15	$45,231.90	1,666
6/8/2022	Marcio Souza	CEO	Buy	1,800	$27.75	$49,950.00	12,612
10/5/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	1,596	$287.25	$458,451.00
10/1/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	1,506	$286.95	$432,146.70
8/23/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	23,493	$285.00	$6,695,505.00
8/18/2021	Marcio Souza	CEO	Buy	636	$236.85	$150,636.60
8/18/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	200	$238.20	$47,640.00
8/2/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	2,666	$236.70	$631,042.20
7/30/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	1,056	$235.20	$248,371.20

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

SEC Filings (Institutional Ownership Changes) for Praxis Precision Medicines (NASDAQ:PRAX)

67.84% of Praxis Precision Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Praxis Precision Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	PCG Wealth Advisors LLC	12,917	$0.79M	0.4%	N/A	0.098%
3/18/2024	Kingdon Capital Management L.L.C.	346,665	$7.72M	1.0%	-93.3%	2.618%
3/11/2024	Vanguard Group Inc.	370,938	$8.26M	0.0%	-93.3%	4.220%
2/15/2024	Barclays PLC	9,245	$0.21M	0.0%	N/A	0.105%
2/15/2024	Sphera Funds Management LTD.	328,986	$7.33M	1.2%	-93.2%	3.742%
2/15/2024	Vanguard Group Inc.	370,938	$8.26M	0.0%	-93.3%	4.219%
2/15/2024	Velan Capital Investment Management LP	345,666	$7.70M	4.5%	-93.3%	3.932%
2/15/2024	PFM Health Sciences LP	656,548	$14.63M	0.9%	-92.6%	7.468%
2/15/2024	Bridgeway Capital Management LLC	21,152	$0.47M	0.0%	-89.5%	0.241%
2/15/2024	Blackstone Inc.	70,273	$1.57M	0.0%	-93.3%	0.799%
2/14/2024	72 Investment Holdings LLC	65,933	$1.47M	6.5%	-93.3%	0.750%
2/14/2024	Point72 Asset Management L.P.	692,252	$15.42M	0.0%	-93.3%	7.874%
2/14/2024	Verition Fund Management LLC	703,000	$15.66M	0.1%	-92.2%	7.996%
2/14/2024	Wildcat Capital Management LLC	16,756	$0.37M	0.1%	N/A	0.191%
2/13/2024	Northern Trust Corp	19,364	$0.43M	0.0%	-93.5%	0.220%
2/13/2024	CIBC Asset Management Inc	173,868	$3.87M	0.0%	-90.5%	1.978%
2/12/2024	DLD Asset Management LP	10,000	$0.22M	0.0%	N/A	0.114%
2/7/2024	Dimensional Fund Advisors LP	13,710	$0.31M	0.0%	-35.1%	0.156%
2/5/2024	Victory Capital Management Inc.	15,705	$0.35M	0.0%	+25.0%	0.179%
2/2/2024	Simplex Trading LLC	1,392	$31K	0.0%	N/A	0.016%
12/18/2023	Vanguard Group Inc.	5,564,114	$9.52M	0.0%	+135.3%	64.925%
12/6/2023	Citigroup Inc.	83,115	$0.14M	0.0%	+44,585.5%	0.969%
11/17/2023	Jacobs Levy Equity Management Inc.	683,379	$1.17M	0.0%	-47.7%	0.532%
11/15/2023	GSA Capital Partners LLP	33,549	$57K	0.0%	+172.8%	0.026%
11/15/2023	Acuta Capital Partners LLC	4,485,000	$7.67M	5.1%	+5.5%	3.489%
11/15/2023	Adage Capital Partners GP L.L.C.	8,780,000	$15.01M	0.0%	+10.7%	6.830%
11/14/2023	Schonfeld Strategic Advisors LLC	632,543	$1.08M	0.0%	-12.1%	0.492%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	56,130	$96K	0.0%	+45.0%	0.044%
11/13/2023	Northern Trust Corp	296,009	$0.51M	0.0%	+145.7%	0.230%
11/13/2023	Acadian Asset Management LLC	1,434,474	$2.45M	0.0%	-7.0%	1.116%
11/13/2023	Silverarc Capital Management LLC	4,117,920	$7.04M	2.1%	+18.5%	3.203%
11/9/2023	Citigroup Inc.	83,115	$0.14M	0.0%	+44,585.5%	0.065%
11/7/2023	Jump Financial LLC	32,659	$56K	0.0%	N/A	0.025%
10/30/2023	CIBC Asset Management Inc	1,825,910	$3.12M	0.0%	+19.3%	1.420%
10/24/2023	Bank of New York Mellon Corp	75,077	$0.13M	0.0%	+409.5%	0.058%
8/15/2023	Y Intercept Hong Kong Ltd	67,177	$77K	0.0%	N/A	0.105%
8/15/2023	Goldman Sachs Group Inc.	153,531	$0.18M	0.0%	-79.8%	0.240%
8/15/2023	Point72 Asset Management L.P.	10,550,000	$12.13M	0.0%	+21,000.0%	16.461%
8/15/2023	Silverarc Capital Management LLC	3,476,162	$4M	1.2%	N/A	5.424%
8/15/2023	Sphera Funds Management LTD.	8,764,334	$10.08M	1.6%	N/A	13.675%
8/15/2023	CIBC Asset Management Inc	1,530,485	$1.76M	0.0%	+19.2%	2.388%
8/14/2023	Cormorant Asset Management LP	9,500,000	$10.93M	0.6%	N/A	14.823%
8/14/2023	Schonfeld Strategic Advisors LLC	719,769	$0.83M	0.0%	+35.4%	1.123%
8/14/2023	State Street Corp	210,605	$0.24M	0.0%	-78.3%	0.329%
8/11/2023	VR Adviser LLC	5,304,410	$6.10M	1.0%	N/A	8.277%
8/11/2023	PEAK6 Investments LLC	74,468	$86K	0.0%	-16.8%	0.116%
8/11/2023	Renaissance Technologies LLC	655,800	$0.75M	0.0%	+72.6%	1.023%
8/11/2023	BlackRock Inc.	603,923	$0.70M	0.0%	-79.1%	0.942%
8/11/2023	Harvard Management Co. Inc.	692,617	$0.80M	0.1%	-11.0%	1.081%
8/11/2023	Geode Capital Management LLC	443,290	$0.51M	0.0%	-46.9%	0.692%
8/11/2023	Northern Trust Corp	120,498	$0.14M	0.0%	-70.3%	0.188%
8/7/2023	Principal Financial Group Inc.	31,771	$37K	0.0%	+66.6%	0.050%
8/7/2023	Acadian Asset Management LLC	1,543,217	$1.77M	0.0%	+10.5%	2.408%
8/4/2023	Maven Securities LTD	1,351,442	$1.55M	0.0%	N/A	2.109%
5/18/2023	JPMorgan Chase & Co.	38,001	$31K	0.0%	+66.1%	0.061%
5/16/2023	State Street Corp	968,570	$0.78M	0.0%	+9.3%	1.560%
5/16/2023	Squarepoint Ops LLC	46,537	$38K	0.0%	+81.7%	0.075%
5/16/2023	Geode Capital Management LLC	835,576	$0.68M	0.0%	+20.5%	1.442%
5/16/2023	Great Point Partners LLC	2,032,550	$1.64M	0.3%	N/A	3.507%
5/16/2023	AQR Capital Management LLC	74,594	$60K	0.0%	-53.5%	0.129%
5/16/2023	Baker BROS. Advisors LP	1,879,915	$1.52M	0.0%	+2.7%	3.243%
5/15/2023	Schonfeld Strategic Advisors LLC	531,634	$0.43M	0.0%	+683.0%	0.917%
5/15/2023	Two Sigma Advisers LP	171,900	$0.14M	0.0%	-61.6%	0.297%
5/15/2023	Two Sigma Investments LP	52,800	$43K	0.0%	-81.1%	0.091%
5/15/2023	Kingdon Capital Management L.L.C.	4,700,000	$3.80M	0.7%	+64.6%	8.109%
5/15/2023	Boothbay Fund Management LLC	71,243	$58K	0.0%	+178.7%	0.123%
5/12/2023	Renaissance Technologies LLC	380,000	$0.31M	0.0%	+4.4%	0.656%
5/12/2023	BlackRock Inc.	2,888,281	$2.34M	0.0%	-2.8%	4.983%
5/12/2023	Bank of America Corp DE	4,025,769	$3.26M	0.0%	+165.7%	6.946%
5/12/2023	PEAK6 Investments LLC	89,468	$72K	0.0%	N/A	0.154%
5/12/2023	CIBC Asset Management Inc	1,284,471	$1.04M	0.0%	+238.3%	2.216%
5/12/2023	Dimensional Fund Advisors LP	247,654	$0.20M	0.0%	+111.1%	0.427%
5/12/2023	Charles Schwab Investment Management Inc.	129,296	$0.11M	0.0%	+17.2%	0.223%
5/11/2023	Acadian Asset Management LLC	1,396,407	$1.13M	0.0%	+3.2%	2.409%
5/8/2023	Federated Hermes Inc.	387,767	$0.31M	0.0%	+5.2%	0.669%
5/4/2023	Los Angeles Capital Management LLC	263,873	$0.21M	0.0%	+99.4%	0.504%
2/28/2023	Voya Investment Management LLC	18,069	$43K	0.0%	N/A	0.034%
2/16/2023	Alliancebernstein L.P.	80,700	$0.19M	0.0%	+26.9%	0.154%
2/15/2023	Public Employees Retirement System of Ohio	50,286	$0.12M	0.0%	-18.5%	0.096%
2/15/2023	Jane Street Group LLC	57,774	$0.14M	0.0%	-44.1%	0.110%
2/15/2023	Susquehanna Fundamental Investments LLC	62,252	$0.15M	0.0%	-14.7%	0.119%
2/15/2023	Schonfeld Strategic Advisors LLC	67,900	$0.16M	0.0%	-39.4%	0.130%
2/15/2023	Squarepoint Ops LLC	25,618	$61K	0.0%	-85.5%	0.049%
2/15/2023	Millennium Management LLC	167,067	$0.40M	0.0%	-83.0%	0.319%
2/15/2023	Morgan Stanley	182,057	$0.43M	0.0%	-33.8%	0.348%
2/15/2023	Man Group plc	306,661	$0.73M	0.0%	+28.1%	0.585%
2/15/2023	Mariner LLC	17,693	$42K	0.0%	+33.1%	0.034%
2/15/2023	Algert Global LLC	26,830	$64K	0.0%	N/A	0.051%
2/15/2023	AQR Capital Management LLC	160,529	$0.38M	0.0%	-36.2%	0.306%
2/15/2023	Atom Investors LP	26,597	$63K	0.0%	N/A	0.051%
2/15/2023	Boothbay Fund Management LLC	25,560	$61K	0.0%	N/A	0.049%
2/14/2023	Price T Rowe Associates Inc. MD	47,933	$0.11M	0.0%	+34.6%	0.091%
2/14/2023	Susquehanna International Group LLP	20,205	$48K	0.0%	-41.9%	0.039%
2/14/2023	Verition Fund Management LLC	1,670,371	$3.98M	0.1%	+84.7%	3.188%
2/14/2023	Kingdon Capital Management L.L.C.	2,855,989	$6.80M	1.4%	+147.1%	5.451%
2/14/2023	Two Sigma Investments LP	278,772	$0.66M	0.0%	-36.9%	0.532%
2/14/2023	EcoR1 Capital LLC	1,585,324	$3.77M	0.1%	+5.9%	3.026%
2/13/2023	Charles Schwab Investment Management Inc.	110,363	$0.26M	0.0%	+31.1%	0.211%
2/13/2023	CIBC Asset Management Inc	379,637	$0.90M	0.0%	N/A	0.725%
2/13/2023	Barclays PLC	10,539	$25K	0.0%	+557.0%	0.020%

Data available starting January 2016

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Today's Range

Now: $46.89

$45.60

$48.19

50 Day Range

MA: $51.09

$40.20

$62.18

52 Week Range

Now: $46.89

$12.45

$67.21

Volume

350,086 shs

Average Volume

318,454 shs

Market Capitalization

$620.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.89

Who are the company insiders with the largest holdings of Praxis Precision Medicines?: Praxis Precision Medicines' top insider investors include:
Marcio Souza (CEO)
Dean J Mitchell (Director)
Timothy Edwin Kelly (CFO)
Alex Nemiroff (General Counsel)
Lauren Mastrocola (Insider)
Jill Desimone (Director)
Learn More about top insider investors at Praxis Precision Medicines.
Who are the major institutional investors of Praxis Precision Medicines?: Praxis Precision Medicines' top institutional investors include:
PCG Wealth Advisors LLC — 0.10%
Learn More about top institutional investors of Praxis Precision Medicines stock.
Which major investors are buying Praxis Precision Medicines stock?: Within the previous quarter, PRAX stock was acquired by institutional investors including:
PCG Wealth Advisors LLC
In the previous year, these company insiders have bought Praxis Precision Medicines stock:
Marcio Souza (CEO)
Dean J Mitchell (Director)
Timothy Edwin Kelly (CFO)
Alex Nemiroff (General Counsel)
Lauren Mastrocola (Insider)
Jill Desimone (Director)
Learn More investors buying Praxis Precision Medicines stock.